BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260]
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7260.htm
Number Citing Articles
1
Nan Zhang, Meilan Xue, Ting Sun, Jia Yang, Zhongqian Pei, Kunpeng Qin. Fucoidan as an Autophagy Regulator: Mechanisms and Therapeutic Potentials for Cancer and Other DiseasesNutrition and Cancer 2021; : 1 doi: 10.1080/01635581.2021.1973045
2
Jack P. Carson, Mark W. Robinson, Grant A. Ramm, Geoffrey N. Gobert. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activationMolecular Biology Reports 2021;  doi: 10.1007/s11033-021-06774-3
3
Omar Ramos-Lopez, Erika Martinez-Lopez, Sonia Roman, Nora A Fierro, Arturo Panduro. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoWorld Journal of Gastroenterology 2015; 21(41): 11552-11566 doi: 10.3748/wjg.v21.i41.11552
4
Xi Chen, Xin Zhang, Ming Du, Chengyan Dong, Li Cao, Rucheng Wei, Changping Liu, Wei Zhai, Bo Wang, Jun Xin. In vivo preclinical PET/CT imaging of carbon-11-labeled aminoglycerol probe for the diagnosis of liver fibrosisAnnals of Nuclear Medicine 2019; 33(11): 806 doi: 10.1007/s12149-019-01391-4
5
Mei-Ling Tsai, Siao-Ping Tsai, Chi-Tang Ho. Tetrahydrocurcumin attenuates carbon tetrachloride-induced hepatic fibrogenesis by inhibiting the activation and autophagy of hepatic stellate cellsJournal of Functional Foods 2017; 36: 418 doi: 10.1016/j.jff.2017.07.031
6
Chao Wu, Weiyang Chen, Hanyan Ding, Dong Li, Guanghua Wen, Chong Zhang, Wanpeng Lu, Ming Chen, Yan Yang. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitroLife Sciences 2019; 239: 116881 doi: 10.1016/j.lfs.2019.116881
7
Yu-Feng Liu, Guo-Chao Niu, Chen-Yang Li, Jin-Bo Guo, Jia Song, Hui Li, Xiao-Lan Zhang. Mechanism of Ulcerative Colitis-Aggravated Liver Fibrosis: The Activation of Hepatic Stellate Cells and TLR4 Signaling Through Gut-Liver AxisFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.695019
8
Zhiping Zeng, Yujing Wu, Yirong Cao, Ziying Yuan, Yuanqing Zhang, David Y. Zhang, Daisuke Hasegawa, Scott L. Friedman, Jinsheng Guo. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cellsLife Sciences 2018; 203: 39 doi: 10.1016/j.lfs.2018.04.017
9
Xi-ji Qin, Jia-xiang Zhang, Rui-lan Wang. Exosomes as mediators and biomarkers in fibrosisBiomarkers in Medicine 2020; 14(8): 697 doi: 10.2217/bmm-2019-0368
10
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Gopakumar C. Valiathan, Solomon K. John. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00034
11
Fei Liu, Changfeng Sun, Yuanfang Chen, Fei Du, Yuxiang Yang, Gang Wu. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling PathwayJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00032
12
Ralf Weiskirchen, Abdo Mahli, Sabine Weiskirchen, Claus Hellerbrand. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levelsFrontiers in Physiology 2015; 6 doi: 10.3389/fphys.2015.00140
13
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesCells 2020; 9(4): 875 doi: 10.3390/cells9040875
14
Tao Guo, Zu-long Liu, Qiang Zhao, Zhi-min Zhao, Cheng-hai Liu. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo Acta Pharmacologica Sinica 2018; 39(9): 1483 doi: 10.1038/aps.2017.175
15
Rocio I.R. Macias, Maria J. Monte, Maria A. Serrano, Jesús M. González-Santiago, Isabel Martín-Arribas, André L. Simão, Rui E. Castro, Javier González-Gallego, José L. Mauriz, Jose J.G. Marin. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeuticsAging 2021; 13(19): 23416 doi: 10.18632/aging.203620
16
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver diseaseGene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
17
Narges Mohammadtaghvaei, Reza Afarin, Fatemeh Mavalizadeh, Elham Shakerian, Samaneh Salehipour Bavarsad, Ghorban Mohammadzadeh. Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-Β-Activated Hepatic Stellate Cell Line LX-2Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.116875
18
12N-Substituted Matrinol Derivatives Inhibited the Expression of Fibrogenic Genes via Repressing Integrin/FAK/PI3K/Akt Pathway in Hepatic Stellate CellsMolecules 2019; 24(20): 3748 doi: 10.3390/molecules24203748
19
Mattareeyapar Phaosri, Salinee Jantrapirom, Mingkwan Na Takuathung, Noppamas Soonthornchareonnon, Seewaboon Sireeratawong, Pensiri Buacheen, Pornsiri Pitchakarn, Wutigri Nimlamool, Saranyapin Potikanond. Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling PathwayInternational Journal of Molecular Sciences 2019; 20(24): 6314 doi: 10.3390/ijms20246314
20
Yu Miao, Yanling Wu, Yingjin Jin, Mengze Lei, Jixing Nan, Xue Wu. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced miceChemico-Biological Interactions 2020; 317: 108945 doi: 10.1016/j.cbi.2020.108945
21
Cositha Santhakumar, Edward J. Gane, Ken Liu, Geoffrey W. McCaughan. Current perspectives on the tumor microenvironment in hepatocellular carcinomaHepatology International 2020; 14(6): 947 doi: 10.1007/s12072-020-10104-3
22
Bisma Rauff, Mark W Douglas. Role of fibrogenic and inflammatory cytokines in HCV-induced fibrosisFuture Virology 2015; 10(12): 1307 doi: 10.2217/fvl.15.102
23
Yan Yu, Zhiyong Xu, Changbo Ou, Qiuxia Wang, Yanhong Zhang, Feng Guo, Pei Gao, Jinyou Ma. The effect of ghrelin on the fibrosis of chicken bursa of fabricius infected with infectious bursal disease virusGeneral and Comparative Endocrinology 2021; 303: 113705 doi: 10.1016/j.ygcen.2020.113705
24
Jie Han, Yaping He, Hui Zhao, Xiaowei Xu. Hypoxia inducible factor‐1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathwayJournal of Cellular Biochemistry 2019; 120(9): 14735 doi: 10.1002/jcb.28734
25
Yufeng Jiang, Chao Wu, Alex Boye, Jiajun Wu, Jiyu Wang, Xiaochuan Yang, Yan Yang. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediationMolecular and Cellular Biochemistry 2015; 406(1-2): 255 doi: 10.1007/s11010-015-2443-x
26
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHBiomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
27
Cho-Rong Bae, Jun Hino, Hiroshi Hosoda, Mikiya Miyazato, Kenji Kangawa. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitisLife Sciences 2018; 209: 349 doi: 10.1016/j.lfs.2018.08.031
28
Qi Cheng, Chen Li, Cheng-fang Yang, Yu-juan Zhong, Dan Wu, Lin Shi, Li Chen, Yong-wen Li, Li Li. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathwaysChemico-Biological Interactions 2019; 299: 131 doi: 10.1016/j.cbi.2018.12.006
29
E. Velázquez-Miranda, M. Díaz-Muñoz, F. G. Vázquez-Cuevas. Purinergic signaling in hepatic diseasePurinergic Signalling 2019; 15(4): 477 doi: 10.1007/s11302-019-09680-3
30
Shenzong Rao, Jie Xiang, Jingsong Huang, Shangang Zhang, Min Zhang, Haoran Sun, Jian Li. PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt/β-catenin signaling pathway and aggravates liver fibrosisCell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0363-2
31
Xueyan Chen, Chuanbo Ding, Wencong Liu, Xinglong Liu, Yingchun Zhao, Yinan Zheng, Ling Dong, Sadia Khatoon, Mingqian Hao, Xiaojuan Peng, Yue Zhang, Huiying Chen. Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in miceEuropean Journal of Pharmacology 2021; 891: 173652 doi: 10.1016/j.ejphar.2020.173652
32
Gerhard Rogler. Fibrostenotic Inflammatory Bowel Disease2018; : 295 doi: 10.1007/978-3-319-90578-5_20
33
Xin Han, YanLing Wu, Qiao Yang, Gang Cao. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosisPharmacology & Therapeutics 2021; 222: 107791 doi: 10.1016/j.pharmthera.2020.107791
34
Tongxi Zhuang, Xinyi Gu, Nian Zhou, Lili Ding, Li Yang, Mingmei Zhou. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): How to properly control the “General (Jiang Jun)” in Chinese medical herbBiomedicine & Pharmacotherapy 2020; 127: 110224 doi: 10.1016/j.biopha.2020.110224
35
Heba M. Adel Abou Zaghla, Aziza Ahmed El Sebai, Ossama Ashraf Ahmed, Ayat Fawzy Ahmed, Azza Abdel Rahman Saab. Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patientsEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00075-x
36
Hsiao-Hsuan Wang, Jian-Hao Huang, Min-Hao Sue, Wei-Chih Ho, Yu-Hsiang Hsu, Kung-Chao Chang, Ming-Shi Chang. Interleukin-24 protects against liver injury in mouse modelsEBioMedicine 2021; 64: 103213 doi: 10.1016/j.ebiom.2021.103213
37
Dishen Chen, Thanh H. Le, Haleh Shahidipour, Scott A. Read, Golo Ahlenstiel. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and ProgressionCells 2019; 8(11): 1324 doi: 10.3390/cells8111324
38
Omar Nunez Lopez, Fredrick J. Bohanon, Xiaofu Wang, Na Ye, Tiziana Corsello, Yesenia Rojas-Khalil, Haijun Chen, Haiying Chen, Jia Zhou, Ravi S. Radhakrishnan. STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosisRSC Advances 2016; 6(102): 100652 doi: 10.1039/C6RA17459K
39
Li Li, Lei Zhang, Xiongqi Zhao, Jun Cao, Jingfeng Li, Guang Chu. Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitroExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7595
40
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent modelsJournal of Molecular Medicine 2020; 98(9): 1203 doi: 10.1007/s00109-020-01950-7
41
Li-Jun Song, Xu-Ren Yin, Sha-Sha Mu, Jia-Huang Li, Hong Gao, Ying Zhang, Pan-Pan Dong, Cong-Jin Mei, Zi-Chun Hua. The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in MiceFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.570524
42
Biyu Hou, Yuerong Zhao, Guifen Qiang, Xiuying Yang, Chunyang Xu, Xi Chen, Chenge Liu, Xiaobo Wang, Li Zhang, Guanhua Du. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic RatsOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/4545321
43
Md. Abdullah Al Mamun, Md. Faruk, Md. Mizanur Rahman, Kamrun Nahar, Fariha Kabir, Md Ashraful Alam, Nusrat Subhan. High Carbohydrate High Fat Diet Induced Hepatic Steatosis and Dyslipidemia Were Ameliorated by Psidium guajava Leaf Powder Supplementation in RatsEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1897237
44
Büsra Öztürk Akcora, Eshwari Dathathri, Ana Ortiz‐Perez, Alexandras Vassilios Gabriël, Gert Storm, Jai Prakash, Ruchi Bansal. TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo The FASEB Journal 2019; 33(8): 9466 doi: 10.1096/fj.201900215RR
45
Veruska Cintia Alexandrino de Souza, Thiago Almeida Pereira, Valéria Wanderley Teixeira, Helotonio Carvalho, Maria Carolina Accioly Brelaz de Castro, Carolline Guimarães D’assunção, Andréia Ferreira de Barros, Camila Lima Carvalho, Virgínia Maria Barros de Lorena, Vláudia Maria Assis Costa, Álvaro Aguiar Coelho Teixeira, Regina Celia Bressan Queiroz Figueiredo, Sheilla Andrade de Oliveira. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stressWorld Journal of Gastroenterology 2017; 23(28): 5146-5157 doi: 10.3748/wjg.v23.i28.5146
46
I. A. Karabak, D. Yu. Lobzin, V. E. Karev. Clinical and immunomorphological predictors of the adverse course of chronic hepatitis CJournal Infectology 2020; 12(2): 79 doi: 10.22625/2072-6732-2020-12-2-79-87
47
Li-ya Mu, Shu-qin Li, Li-xin Tang, Rui Li. Efficacy and Safety of Emricasan in Liver Cirrhosis and/or FibrosisClinics 2021; 76 doi: 10.6061/clinics/2021/e2409
48
Guo-wen Li, Xue-feng Yang, Nian Fu, Yan Ou-yang, Kai Qing. Relation Between Cellular Senescence and Liver DiseasesChinese Medical Sciences Journal 2016; 31(2): 121 doi: 10.1016/S1001-9294(16)30036-0
49
Eszter Regős, Hadeer Hesham Abdelfattah, Andrea Reszegi, László Szilák, Klára Werling, Gábor Szabó, András Kiss, Zsuzsa Schaff, Ilona Kovalszky, Kornélia Baghy. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14Matrix Biology 2018; : 474 doi: 10.1016/j.matbio.2018.02.008
50
Md Ashraful Alam, Abu Taher Sagor, Nabila Tabassum, Anayt Ulla, Manik Chandra Shill, Ghazi Muhammad Sayedur Rahman, Hemayet Hossain, Hasan Mahmud Reza. Caffeic acid rich Citrus macroptera peel powder supplementation prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated ratsClinical Phytoscience 2018; 4(1) doi: 10.1186/s40816-018-0074-y
51
Bingying Wang, Huan Yang, Yinyin Fan, Yong Yang, Wei Cao, Yanwei Jia, Ying Cao, Kangyun Sun, Zhi Pang, Hong Du. 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cellOncotarget 2017; 8(64): 107603 doi: 10.18632/oncotarget.22539
52
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseasesNutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
53
Chong-Yang Zhang, Wei-Gang Yuan, Pei He, Jia-Hui Lei, Chun-Xu Wang. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targetsWorld Journal of Gastroenterology 2016; 22(48): 10512-10522 doi: 10.3748/wjg.v22.i48.10512
54
Xia Yao, Jing Wang, Jiajing Zhu, Xiaoli Rong. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosisStem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01891-5
55
Brenda de Oliveira da Silva, Letícia Ferrreira Ramos, Karen C. M. Moraes. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosisCell Biology International 2017; 41(9): 946 doi: 10.1002/cbin.10790
56
Dorothy Rosique-Oramas, Moises Martinez-Castillo, Carolina Guzman, José Luis Pérez Hernández, Jacqueline Cordova-Gallardo, Luis Very-Pineda, Fatima Higuera-De La Tijera, Daniel Santana-Vargas, Eduardo Montalvo-Jave, Francisco Sanchez-Avila, Paula Cordero Perez, Linda Muñoz-Espinosa, David Kershenobich, Gabriela Gutiérrez-Reyes. Liver Cirrhosis - Debates and Current Challenges2019;  doi: 10.5772/intechopen.84351
57
David Kershenobich, Nayelli Flores. Hepatitis B and C2020;  doi: 10.5772/intechopen.83557
58
Shuang Hu, Su-wen Li, Qi Yan, Xiang-peng Hu, Liang-yun Li, Hong Zhou, Lin-xin Pan, Jun Li, Chuan-pu Shen, Tao Xu. Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver diseasePharmacological Research 2019; 150: 104501 doi: 10.1016/j.phrs.2019.104501
59
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infectionCytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
60
Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Irene Kim, Dodam Moon, Hyomin Park, Seo-Yeon Lee, Hong Sug Kim, Dae Won Jun, Sung-Hye Park, Hyo-Soo Kim. Hepatic stellate cell–specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosisJournal of Experimental Medicine 2020; 217(6) doi: 10.1084/jem.20190402
61
Yani Liu, Jianhong Wu, Zhongfang Li, Ying Luo, Fandian Zeng, Shaojun Shi. Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human StudyEuropean Journal of Drug Metabolism and Pharmacokinetics 2017; 42(1): 37 doi: 10.1007/s13318-015-0316-z
62
Hyuk Moon, Kyungjoo Cho, Sunyeong Shin, Do Kim, Kwang-Hyub Han, Simon Ro. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling PathwayInternational Journal of Molecular Sciences 2019; 20(3): 581 doi: 10.3390/ijms20030581
63
Mohamed E. Shaker, Nada H. Eisa, Abdelaziz Elgaml, Ahmed El-Mesery, Mohamed El-Shafey, Mohamed El-Dosoky, Mohammed El-Mowafy, Mohamed El-Mesery. Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in ratsLife Sciences 2021; 286: 120040 doi: 10.1016/j.lfs.2021.120040
64
Merve Özel, Mevlut Baskol, Hilal Akalın, Gulden Baskol. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial–Mesenchymal Transition (EMT)Cell Biochemistry and Biophysics 2021; 79(2): 349 doi: 10.1007/s12013-021-00974-1
65
Tiago L. Duarte, Carolina Caldas, Ana G. Santos, Sandro Silva-Gomes, Andreia Santos-Gonçalves, Maria João Martins, Graça Porto, José Manuel Lopes. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosisRedox Biology 2017; 11: 157 doi: 10.1016/j.redox.2016.11.013
66
Zhen Li, Qian Ding, Li-Ping Ling, Ying Wu, Dong-Xiao Meng, Xiao Li, Chun-Qing Zhang. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells <i>in vivo</i> and <i>in vitro</i> by activating AMP-activated protein kinaseWorld Journal of Gastroenterology 2018; 24(7): 819-832 doi: 10.3748/wjg.v24.i7.819
67
Gang Cao, Ruyi Zhu, Ting Jiang, Dongxin Tang, Hiu Yee Kwan, Tao Su. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signalingPhytomedicine 2019; 63: 153055 doi: 10.1016/j.phymed.2019.153055
68
Xuan Zhang, Ming-Gen Hu, Ke Pan, Chong-Hui Li, Rong Liu. 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic FibrosisStem Cells International 2016; 2016: 1 doi: 10.1155/2016/4626073
69
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
70
Reham M. Dawood, Mai A. El-Meguid, Ghada Maher Salum, Mostafa K. El Awady. Key Players of Hepatic FibrosisJournal of Interferon & Cytokine Research 2020; 40(10): 472 doi: 10.1089/jir.2020.0059
71
Sheng Wang, Chen Shuai, Songsen Gao, Jia Jiang, Jiajie Luan, Xiongwen Lv. Chemokine CXCL14 acts as a potential genetic target for liver fibrosisInternational Immunopharmacology 2020; 89: 107067 doi: 10.1016/j.intimp.2020.107067
72
R. Mihaylov, B. Pencheva, D. Stoeva, A. Ruseva. Non-invasive Diagnostics of Liver FibrosisActa Medica Bulgarica 2017; 44(1): 50 doi: 10.1515/amb-2017-0009
73
Qin Yu, Xiaoqin Xiong, Lei Zhao, Tingting Xu, Qianhua Wang. Antifibrotic effects of specific siRNA targeting connective tissue growth factor delivered by polyethyleneimine‑functionalized magnetic iron oxide nanoparticles on LX‑2 cellsMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10834
74
Yufei Yan, Jiefei Zeng, Linhao Xing, Changyong Li. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell ActivationBiomedicines 2021; 9(8): 1014 doi: 10.3390/biomedicines9081014
75
Na-Hyun Kim, Jeong-Doo Heo, Tae Bum Kim, Jung-Rae Rho, Min Hye Yang, Eun Ju Jeong. Protective Effects of Ethyl Acetate Soluble Fraction of <i>Limonium tetragonum</i> on Diethylnitrosamine-Induced Liver Fibrosis in RatsBiological & Pharmaceutical Bulletin 2016; 39(6): 1022 doi: 10.1248/bpb.b15-01047
76
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and TreatmentFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
77
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Options of non-invasive assessment of liver fibrosis based on the clinical dataOrvosi Hetilap 2015; 156(2): 43 doi: 10.1556/OH.2015.30069
78
Valentina Masola, Giovanni Gambaro, Maurizio Onisto. HeparanaseAdvances in Experimental Medicine and Biology 2020; 1221: 669 doi: 10.1007/978-3-030-34521-1_27
79
Xianyao Wang, Huizhen Wang, Junhou Lu, Zhanhui Feng, Zhongshan Liu, Hailiang Song, Heng Wang, Yanhua Zhou, Jianwei Xu. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis ModelTissue Engineering and Regenerative Medicine 2020; 17(5): 683 doi: 10.1007/s13770-020-00276-2
80
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse ModelNutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
81
Syed Yeasin Arafat, Mohammad Nayeem, Sharfiat Jahan, Zarifa Karim, Hasan Mahmud Reza, Md Hemayet Hossain, Mohammad Shohel, Md Ashraful Alam. Ellagic acid rich Momordica charantia fruit pulp supplementation prevented oxidative stress, fibrosis and inflammation in liver of alloxan induced diabetic ratsOriental Pharmacy and Experimental Medicine 2016; 16(4): 267 doi: 10.1007/s13596-016-0242-x
82
Roberta Sferra, Antonella Vetuschi, Simona Pompili, Eugenio Gaudio, Silvia Speca, Giovanni Latella. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosisPathology - Research and Practice 2017; 213(1): 58 doi: 10.1016/j.prp.2016.11.004
83
Cai Zhang, Xing Tian, Ke Zhang, Guo-Yu Li, Hang-Yu Wang, Jin-Hui Wang. Protective effects of <i>Foeniculum vulgare</i> root bark extract against carbon tetrachloride-induced hepatic fibrosis in miceWorld Journal of Gastroenterology 2017; 23(31): 5722-5731 doi: 10.3748/wjg.v23.i31.5722
84
Jana Enderes, Jessica Teschke, Steffen Manekeller, Tim O. Vilz, Jörg C. Kalff, Tim R. Glowka. Chronic Liver Disease Increases Mortality Following PancreatoduodenectomyJournal of Clinical Medicine 2021; 10(11): 2521 doi: 10.3390/jcm10112521
85
Xuanyan Cai, Jiajia Wang, Jincheng Wang, Qian Zhou, Bo Yang, Qiaojun He, Qinjie Weng. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapyPharmacological Research 2020; 155: 104720 doi: 10.1016/j.phrs.2020.104720
86
Tianyu Niu, Weixiao Niu, Yunyang Bao, Ting Liu, Danqing Song, Yinghong Li, Hongwei He. Discovery of Matrinic Thiadiazole Derivatives as a Novel Family of Anti-Liver Fibrosis Agents via Repression of the TGFβ/Smad PathwayMolecules 2018; 23(7): 1644 doi: 10.3390/molecules23071644
87
Jae Hyun Han, Ok-Hee Kim, Sang Chul Lee, Kee-Hwan Kim, Jung Hyun Park, Jae Im Lee, Kyung Hee Lee, Ha-Eun Hong, Haeyeon Seo, Ho Joong Choi, Ji Hyeon Ju, Say-June Kim. A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem CellsInternational Journal of Molecular Sciences 2019; 20(24): 6302 doi: 10.3390/ijms20246302
88
Maria Francesca Secchi, Marika Crescenzi, Valentina Masola, Francesco Paolo Russo, Annarosa Floreani, Maurizio Onisto. Heparanase and macrophage interplay in the onset of liver fibrosisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14946-0
89
Timea Csak, Shashi Bala, Dora Lippai, Karen Kodys, Donna Catalano, Arvin Iracheta-Vellve, Gyongyi Szabo, Rafael Aldabe. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of SteatohepatitisPLOS ONE 2015; 10(6): e0129251 doi: 10.1371/journal.pone.0129251
90
Radan Bruha, Libor Vitek, Vaclav Smid. Osteopontin – A potential biomarker of advanced liver diseaseAnnals of Hepatology 2020; 19(4): 344 doi: 10.1016/j.aohep.2020.01.001
91
A. T. Fiyas, N. F. Vasilevskaya, E. F. Pishchyk. LIVER FIBROSIS: MECHANISMS AND THERAPY APPROACHESHepatology and Gastroenterology 2019; 3(2): 127 doi: 10.25298/2616-5546-2019-3-2-127-134
92
Yu Huang, Xiangxue Fan, Ran Tao, Qiqin Song, Likui Wang, Hongyue Zhang, Hongyan Kong, Jiaquan Huang. Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K / AKT signaling pathway Journal of Cellular Physiology 2018; 233(10): 6693 doi: 10.1002/jcp.26469
93
Yi Zhang, Hui Miao, Huida Guan, Changhong Wang, Zhengtao Wang, Lili Ji. Long-term diosbulbin B treatment induced liver fibrosis in miceChemico-Biological Interactions 2019; 298: 15 doi: 10.1016/j.cbi.2018.10.015
94
Shukai Zhan, Na Li, Caiguang Liu, Ren Mao, Dongxuan Wu, Tong Li, Minhu Chen, Xiaojun Zhuang, Zhirong Zeng. Intestinal Fibrosis and Gut Microbiota: Clues From Other OrgansFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.694967
95
L. V. Tarasova, V. N. Diomidova, N. V. Tolmacheva, Yu. V. Tsyganova, A. L. Ivanova, J. V. Maslova, E. V. Barsukova. Correlation of secreted frizzled related protein-4 adipokin expression and expression of fatty liver changes under the conditions of a chronic experimentExperimental and Clinical Gastroenterology 2021; 1(5): 44 doi: 10.31146/1682-8658-ecg-189-5-44-48
96
Kristina Duspara, Kristina Bojanic, Josipa Ivanusic Pejic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Nincevic, Robert Smolic, Aleksandar Vcev, Marija Glasnovic, Ines Bilic Curcic, Martina Smolic. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An UpdateJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00065
97
Marta Costas-Rodríguez, Thibaut Van Acker, Agustina A. M. B. Hastuti, Lindsey Devisscher, Sanne Van Campenhout, Hans Van Vlierberghe, Frank Vanhaecke. Laser ablation-inductively coupled plasma-mass spectrometry for quantitative mapping of the copper distribution in liver tissue sections from mice with liver disease induced by common bile duct ligationJournal of Analytical Atomic Spectrometry 2017; 32(9): 1805 doi: 10.1039/C7JA00134G
98
Patric Schyman, Richard L. Printz, Shanea K. Estes, Kelli L. Boyd, Masakazu Shiota, Anders Wallqvist. Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and KidneyFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01272
99
Reza Afarin, Hossein Babaahmadi Rezaei, Hamid Yaghooti, Narges Mohammadtaghvaei. Fibroblast Growth Factor 21 Reduces Cholesterol-Induced Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3C Signaling Pathway in LX2 CellsHepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.113321
100
Rong Wu, Shu Dong, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Ping Liu, Shi-Bing Su. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic AnalysisMolecules 2019; 24(2): 338 doi: 10.3390/molecules24020338
101
Xiaoli Rong, Yanyan Yang, Guokun Zhang, Haiying Zhang, Chunyi Li, Yimin Wang. Antler stem cells as a novel stem cell source for reducing liver fibrosisCell and Tissue Research 2020; 379(1): 195 doi: 10.1007/s00441-019-03081-z
102
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019Cells 2019; 8(11): 1419 doi: 10.3390/cells8111419
103
Xiuqing Li, Hui Zhang, Lijuan Pan, Haiou Zou, Xiaonan Miao, Jing Cheng, Youshan Wu. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide‑induced hepatic fibrosis in ratsExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7534
104
Büsra Öztürk Akcora, Alexandros Vassilios Gabriël, Ana Ortiz‐Perez, Ruchi Bansal. Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cellsFASEB BioAdvances 2020; 2(2): 77 doi: 10.1096/fba.2019-00070
105
Dan-dan Xu, Xiao-feng Li, Yu-huan Li, Yan-hui Liu, Cheng Huang, Xiao-ming Meng, Jun Li. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cellsBiochemical and Biophysical Research Communications 2018; 498(1): 199 doi: 10.1016/j.bbrc.2017.11.178
106
Pratima Dibba, Andrew Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Khan, Donghee Kim, Aijaz Ahmed. The Role of Cannabinoids in the Setting of CirrhosisMedicines 2018; 5(2): 52 doi: 10.3390/medicines5020052
107
A. G. Lishnevska, M. D. Chemych. CORRELATIONS BETWEEN CLINICAL, HEMATOLOGICAL, BIOCHEMICAL AND INTEGRATIVE INDICATORS AND THE DEGREE OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS CHepatology and Gastroenterology 2020; 4(1): 45 doi: 10.25298/2616-5546-2020-4-1-45-54
108
Sarah Y. Neshat, Victor M. Quiroz, Yuanjia Wang, Sebastian Tamayo, Joshua C. Doloff. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic InterventionsInternational Journal of Molecular Sciences 2021; 22(13): 6777 doi: 10.3390/ijms22136777
109
Ming-ming Ni, Tao Xu, Ya-rui Wang, Ying-hua He, Qun Zhou, Cheng Huang, Xiao-ming Meng, Jun Li. Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cellsJournal of Physiology and Biochemistry 2016; 72(1): 9 doi: 10.1007/s13105-015-0452-6
110
Li Li, Jianghua Ran, Lan Li, Gang Chen, Shengning Zhang, Yingjia Wang. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in�vivo and in�vitroMolecular Medicine Reports 2020;  doi: 10.3892/mmr.2020.10997
111
Alessandra Breschi, Manuel Muñoz-Aguirre, Valentin Wucher, Carrie A. Davis, Diego Garrido-Martín, Sarah Djebali, Jesse Gillis, Dmitri D. Pervouchine, Anna Vlasova, Alexander Dobin, Chris Zaleski, Jorg Drenkow, Cassidy Danyko, Alexandra Scavelli, Ferran Reverter, Michael P. Snyder, Thomas R. Gingeras, Roderic Guigó. A limited set of transcriptional programs define major cell typesGenome Research 2020; 30(7): 1047 doi: 10.1101/gr.263186.120
112
Zeinab Abedian, Sadegh Fattahi, Roghayeh Pourbagher, Sahar Edrisi, Amrollah Mostafazadeh. Sustained small and intermediate size proteins expression in phorbol 12-myristate 13-acetate/ionomycine prolonged stimulated human fibroblastsAsian Pacific Journal of Tropical Biomedicine 2017; 7(5): 432 doi: 10.1016/j.apjtb.2017.01.015
113
Mohamed A. Morsy, Anroop B. Nair. Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriersInternational Journal of Pharmaceutics 2018; 552(1-2): 241 doi: 10.1016/j.ijpharm.2018.10.003
114
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Gwang-mu Choi, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseasesClinics 2021; 76 doi: 10.6061/clinics/2021/e2501
115
Farooq Riaz, Dongmin Li. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver FibrosisCurrent Gene Therapy 2019; 19(5): 305 doi: 10.2174/1566523219666191107113046
116
Daphne Pinheiro, Luana Leirós, Juliana Barbosa Torreão Dáu, Ana Carolina Stumbo, Alessandra Alves Thole, Erika Afonso Costa Cortez, Carlos Alberto Mandarim-de-Lacerda, Lais de Carvalho, Simone Nunes de Carvalho, Maria Cristina Vinci. Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic micePLOS ONE 2017; 12(11): e0187970 doi: 10.1371/journal.pone.0187970
117
Juan Xiao, Chunmei Jin, Zhixue Liu, Shujing Guo, Xiaochuan Zhang, Xin Zhou, Xue Wu. The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agentsOrganic & Biomolecular Chemistry 2015; 13(26): 7257 doi: 10.1039/C5OB00710K
118
Yehong Liu, Puye Yang, Na Chen, Shumei Lin, Min Liu. Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosisInternational Journal of Molecular Medicine 2016; 38(4): 1093 doi: 10.3892/ijmm.2016.2716
119
Chun-Hung Chiu, Chun-Chao Chang, Shiang-Ting Lin, Charng-Cherng Chyau, Robert Peng. Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute HepatotoxicityInternational Journal of Molecular Sciences 2016; 17(7): 1128 doi: 10.3390/ijms17071128
120
G&uuml;ls&uuml;m &Ouml;zlem Elpek. Neuropilins and liverWorld Journal of Gastroenterology 2015; 21(23): 7065-7073 doi: 10.3748/wjg.v21.i23.7065
121
Hui Miao, Yi Zhang, Zhenlin Huang, Bin Lu, Lili Ji. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of ActionThe American Journal of Chinese Medicine 2019; 47(02): 351 doi: 10.1142/S0192415X19500174
122
Shanshan Zhu, Tao Wang, Fei Luo, Huawen Li, Qing Jia, Taiping He, Hongfu Wu, Tangbin Zou. Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathwayMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10025
123
Mishghan Zehra, James C. Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic FibrosisInternational Journal of Molecular Sciences 2020; 21(13): 4737 doi: 10.3390/ijms21134737
124
Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosisAdvanced Drug Delivery Reviews 2018; 129: 54 doi: 10.1016/j.addr.2018.01.009
125
Fang Yang, Guo-Xun Chen. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosisWorld Journal of Gastroenterology 2018; 24(36): 4132-4151 doi: 10.3748/wjg.v24.i36.4132
126
Beomseok Son, TaeWoo Kwon, Sungmin Lee, IkJoon Han, Wanyeon Kim, HyeSook Youn, BuHyun Youn. CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress- and ROS-dependent mechanismsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology 2017; 313(5): L916 doi: 10.1152/ajplung.00144.2017
127
Joselyn Allen, Jingtao Zhang, Michael D. Quickel, Mary Kennett, Andrew D. Patterson, Pamela A. Hankey-Giblin. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse ModelJournal of Proteome Research 2018; 17(9): 3268 doi: 10.1021/acs.jproteome.8b00379
128
Magisetty Obulesu. Turmeric and Curcumin for Neurodegenerative Diseases2021; : 139 doi: 10.1016/B978-0-12-822448-9.00004-2
129
Federico Lucantoni, Andreu Martínez‐Cerezuela, Aleksandra Gruevska, Ángela B Moragrega, Víctor M Víctor, Juan V Esplugues, Ana Blas‐García, Nadezda Apostolova. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?The Journal of Pathology 2021; 254(3): 216 doi: 10.1002/path.5678
130
Michał Kukla, Marek Waluga, Michał Żorniak, Agnieszka Berdowska, Piotr Wosiewicz, Tomasz Sawczyn, Rafał J Bułdak, Marek Ochman, Katarzyna Ziora, Tadeusz Krzemiński, Marek Hartleb. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosisWorld Journal of Gastroenterology 2017; 23(14): 2613-2624 doi: 10.3748/wjg.v23.i14.2613
131
Mariia Zadorozhna, Sante Di Gioia, Massimo Conese, Domenica Mangieri. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatmentMolecular Biology Reports 2020; 47(3): 2279 doi: 10.1007/s11033-020-05290-0
132
Nilofer Sayed, Amit Khurana, Mohd Aslam Saifi, Mandip Singh, Chandraiah Godugu. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signalingBioFactors 2019; 45(6): 959 doi: 10.1002/biof.1546
133
Calen A. Steiner, Peter D. R. Higgins. Fibrostenotic Inflammatory Bowel Disease2018; : 347 doi: 10.1007/978-3-319-90578-5_23
134
Erika Ramos-Tovar, Laura D. Buendia-Montaño, Silvia Galindo-Gómez, Erika Hernández-Aquino, Víctor Tsutsumi, Pablo Muriel. Stevia prevents experimental cirrhosis by reducing hepatic myofibroblasts and modulating molecular profibrotic pathwaysHepatology Research 2019; 49(2): 212 doi: 10.1111/hepr.13275
135
De Ji, Qi Zhao, Yuwen Qin, Huangjin Tong, Qiaohan Wang, Mengting Yu, Chunqin Mao, Tulin Lu, Jinchun Qiu, Chengxi Jiang. Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathwayCell Biology International 2021; 45(9): 1866 doi: 10.1002/cbin.11607
136
Haiying Dong, Hongyan Guo, Yini Liang, Xing Wang, Yingcai Niu. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activationin vitroFree Radical Research 2017; 51(2): 167 doi: 10.1080/10715762.2017.1290233
137
Ikuo Nakamura, Faizal Z. Asumda, Catherine D. Moser, Yoo Na N. Kang, Jin-Ping Lai, Lewis R. Roberts. Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling PathwayCancers 2021; 13(21): 5279 doi: 10.3390/cancers13215279
138
Dong Ji, Guo‐Feng Chen, Jin‐Cheng Wang, Li‐Hua Cao, Fengmin Lu, Xiao‐Xin Mu, Xiao‐Yu Zhang, Xiao‐Jie Lu. Identification of TAF1 , HNF4A , and CALM2 as potential therapeutic target genes for liver fibrosis Journal of Cellular Physiology 2019; 234(6): 9045 doi: 10.1002/jcp.27579
139
E. I. Lebedeva, O. D. Myadelets. CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESISHepatology and Gastroenterology 2019; 3(2): 119 doi: 10.25298/2616-5546-2019-3-2-119-126
140
Jelske N. van der Veen, Susanne Lingrell, Xia Gao, Abhijit Takawale, Zamaneh Kassiri, Dennis E. Vance, René L. Jacobs. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferaseJournal of Lipid Research 2017; 58(4): 656 doi: 10.1194/jlr.M070631
141
Joel T. Haas, Sven Francque, Bart Staels. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver DiseaseAnnual Review of Physiology 2016; 78(1): 181 doi: 10.1146/annurev-physiol-021115-105331
142
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosisCell Death & Disease 2019; 10(1) doi: 10.1038/s41419-018-1272-8
143
Hang Lyu, Huihui Wang, Lu Li, Jiayu Zhu, Feng Chen, Yannan Chen, Cuijie Liu, Jingqi Fu, Bei Yang, Qiang Zhang, Yuanyuan Xu, Jingbo Pi. Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responsesFree Radical Biology and Medicine 2020; 150: 136 doi: 10.1016/j.freeradbiomed.2020.02.015
144
Rafael Cierpka, Ralf Weiskirchen, Anastasia Asimakopoulos. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 ActivationCells 2021; 10(9): 2184 doi: 10.3390/cells10092184
145
Chun-Hung Liu, Kun-Ming Chan, Tsaiyu Chiang, Jia-Yu Liu, Guann-Gen Chern, Fu-Fei Hsu, Yu-Hsuan Wu, Ya-Chi Liu, Yunching Chen. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver FibrosisMolecular Pharmaceutics 2016; 13(7): 2253 doi: 10.1021/acs.molpharmaceut.5b00913
146
Mengping Huang, Xin Lu, Xiaofeng Wang, Jian Shu. Diffusion tensor imaging quantifying the severity of chronic hepatitis in ratsBMC Medical Imaging 2020; 20(1) doi: 10.1186/s12880-020-00466-3
147
Burkhard Kleuser. Divergent Role of Sphingosine 1-Phosphate in Liver Health and DiseaseInternational Journal of Molecular Sciences 2018; 19(3): 722 doi: 10.3390/ijms19030722
148
Md Mizanur Rahman, Awale Yousuf Muse, D.M. Isha Olive Khan, Ismaile Hussein Ahmed, Nusrat Subhan, Hasan Mahmud Reza, Md Ashraful Alam, Lutfun Nahar, Satyajit Dey Sarker. Apocynin prevented inflammation and oxidative stress in carbon tetra chloride induced hepatic dysfunction in ratsBiomedicine & Pharmacotherapy 2017; 92: 421 doi: 10.1016/j.biopha.2017.05.101
149
Nancy Magee, An Zou, Yuxia Zhang. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5170402
150
Naglaa A. Bayomy, Gehan M. Soliman, Eman Z. Abdelaziz. Effect of Potassium Bromate on the Liver of Adult Male Albino Rat and A Possible Protective Role of Vitamin C: Histological, Immunohistochemical, and Biochemical StudyThe Anatomical Record 2016; 299(9): 1256 doi: 10.1002/ar.23386
151
Weiwei Li, Mingjuan Deng, Jiahui Gong, Xiaoying Zhang, Shaoyang Ge, Liang Zhao. Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun SignalingFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.729583
152
Xiankui Li, Lei Wang, Cai Chen. Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06318-5
153
Zongqiang Hu, Li Li, Jianghua Ran, Guang Chu, Hongqiang Gao, Licheng Guo, Jiapeng Chen. miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitroAnnals of Hepatology 2019; 18(6): 825 doi: 10.1016/j.aohep.2019.06.016
154
Haojie Wang, Yumei Liu, Dongmei Wang, Yaolu Xu, Ruiqi Dong, Yuxiang Yang, Qiongxia Lv, Xiaoguang Chen, Ziqiang Zhang. The Upstream Pathway of mTOR-Mediated Autophagy in Liver DiseasesCells 2019; 8(12): 1597 doi: 10.3390/cells8121597
155
Lindolfo da Silva Meirelles, Renan Fava Marson, Maria Inês Gonzalez Solari, Nance Beyer Nardi. Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and RepairCells 2020; 9(1): 188 doi: 10.3390/cells9010188
156
Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver FibrosisCells 2019; 8(11): 1356 doi: 10.3390/cells8111356
157
Salwa A. Ibrahim, Mervat Z. Mohamed, Nashwa F. El-Tahawy, Aly M. Abdelrahman. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino ratsCanadian Journal of Physiology and Pharmacology 2021; 99(3): 313 doi: 10.1139/cjpp-2020-0159
158
Shu Dong, Fei-fei Cai, Qi-long Chen, Ya-nan Song, Yang Sun, Bin Wei, Xiao-yan Li, Yi-yang Hu, Ping Liu, Shi-bing Su. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysisActa Pharmacologica Sinica 2018; 39(6): 930 doi: 10.1038/aps.2017.150
159
Özlem Akdoğan, Ayşegül Atak Yücel, Zeynep Gök Sargin, Cemile Sönmez, Güldal Esendağli Yilmaz, Seren Özenirler. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis MarkerJournal of Clinical and Experimental Hepatology 2019; 9(1): 29 doi: 10.1016/j.jceh.2018.02.001
160
Verónica Miguel, Santiago Lamas. Oxidative Stress2020; : 779 doi: 10.1016/B978-0-12-818606-0.00037-7
161
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68317
162
Anna Blázovics. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases2021; : 57 doi: 10.1016/B978-0-12-816488-4.00010-3
163
Mengyao Ma, Wenhua Xie, Xi Li. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic SteatohepatitisInternational Journal of General Medicine 2021; : 3163 doi: 10.2147/IJGM.S317785
164
Lifeng Qin, Jinmei Qin, Xiumei Zhen, Qian Yang, Liyi Huang. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:A study in vitro and in vivoBiomedicine & Pharmacotherapy 2018; 101: 599 doi: 10.1016/j.biopha.2018.02.091
165
Mostafa M. Salah, Ahmed A. Ashour, Tamer M. Abdelghany, Abdel-Aziz H. Abdel-Aziz, Salama A. Salama. Pirfenidone alleviates concanavalin A-induced liver fibrosis in miceLife Sciences 2019; 239: 116982 doi: 10.1016/j.lfs.2019.116982
166
Omar A. Mesarwi, Mi-Kyung Shin, Shannon Bevans-Fonti, Christina Schlesinger, Janet Shaw, Vsevolod Y. Polotsky, Matias A Avila. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver DiseasePLOS ONE 2016; 11(12): e0168572 doi: 10.1371/journal.pone.0168572
167
YA-LEI ZHAO, RONG-TAO ZHU, YU-LING SUN. Epithelial-mesenchymal transition in liver fibrosisBiomedical Reports 2016; 4(3): 269 doi: 10.3892/br.2016.578
168
Piotr Czekaj, Mateusz Król, Łukasz Limanówka, Marcin Michalik, Katarzyna Lorek, Roberto Gramignoli. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapyEuropean Journal of Pharmacology 2019; 861: 172597 doi: 10.1016/j.ejphar.2019.172597
169
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108